Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice
2008

HIV Prevention in Mice

Sample size: 21 publication Evidence: high

Author Information

Author(s): Denton Paul W, Estes Jacob D, Sun Zhifeng, Othieno Florence A, Wei Bangdong L, Wege Anja K, Powell Daniel A, Payne Deborah, Haase Ashley T, Garcia J. Victor

Primary Institution: University of Texas Southwestern Medical Center at Dallas

Hypothesis

Can humanized BLT mice be used to study vaginal transmission of HIV-1 and the effectiveness of pre-exposure prophylaxis?

Conclusion

Pre-exposure prophylaxis with antiretroviral drugs can completely prevent vaginal transmission of HIV-1 in humanized BLT mice.

Supporting Evidence

  • 88% of BLT mice inoculated with HIV-1 became infected without pre-exposure prophylaxis.
  • None of the BLT mice that received FTC/TDF showed evidence of HIV-1 infection.
  • The study highlights the potential of humanized mice for testing HIV prevention strategies.

Takeaway

Scientists used special mice that have human-like immune systems to see if a medicine could stop HIV from spreading through sex, and it worked!

Methodology

The study involved using humanized BLT mice to test the effectiveness of pre-exposure prophylaxis against HIV-1 infection after intravaginal exposure.

Limitations

The BLT model may not predict clinical outcomes in humans due to differences in drug metabolism and immune response.

Participant Demographics

Humanized BLT mice with reconstituted human immune systems.

Statistical Information

P-Value

0.006

Statistical Significance

p = 0.006

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication